IM Cannabis Corp. Announces Voluntary Delisting from the Canadian Securities Exchange
TORONTO and GLIL YAM, Israel, May 28, 2025 — IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, has announced its intention to voluntarily delist its common shares from the Canadian Securities Exchange (CSE). This decision will not impact the company’s listing on NASDAQ, where its shares will continue to trade under the symbol “IMCC.”
The company has cited potential transactions that could be hindered by remaining listed on the CSE. These transactions, if completed while listed on the CSE, would impose unnecessary burdensome costs, require additional approvals, and cause delays. By delisting from the CSE, IM Cannabis aims to streamline its operations and focus on its strategic objectives without the encumbrances associated with dual listings.
Company Overview
IM Cannabis Corp. is a health care company operating in the cannabis sector, specializing in harvesting, distribution, growing, and production. Headquartered in Israel, the company serves its customers with a range of pharmaceutical products. More information about their offerings can be found on their website at www.imcannabis.com .
Financial Snapshot
- Sector: Health Care
- Primary Exchange: Nasdaq
- Currency: USD
- Close Price (2025-05-22): $1.91
- 52 Weeks High (2024-11-28): $4.49
- 52 Weeks Low (2025-04-21): $1.29
- Market Cap: $7,000,000 USD
- Price Earnings Ratio: -1.17
Recent Corporate Updates
On May 27, 2025, IM Cannabis provided corporate updates, including results from its annual general and special meeting. These updates were part of a series of communications following earlier releases on April 11, 2025, and May 7, 2025. The company continues to focus on its strategic initiatives and operational improvements.
IM Cannabis Corp. remains committed to its mission of providing high-quality medical cannabis products and services, leveraging its international presence and expertise in the health care sector.